LivaNova LIVN
NASDAQ LIVN
$78.00 -2.84 (-3.51%)
At close: Aug 20, 2026 · 1:33 PM UTC

LivaNova (LIVN) Total Non-Current Liabilities (2015 - 2026)

LivaNova (LIVN) posted Total Non-Current Liabilities of $1.3 billion for Q1 2026, down 8.31% sequentially from $1.4 billion in Q4 2025, and down 15.33% YoY from $1.5 billion in Q1 2025.

LivaNova (LIVN) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends

LivaNova has reported Total Non-Current Liabilities for 12 years, with the latest figure at $1.3 billion in Q1 2026.

  • Quarterly Total Non-Current Liabilities fell 15.33% year-over-year to $1.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 billion (down 15.33% YoY) and the FY2025 annual result came in at $1.4 billion, up 19.48% from the prior year.
  • Total Non-Current Liabilities fell to $1.3 billion in Q1 2026 per LIVN's latest filing, from $1.4 billion in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $1.5 billion in Q1 2025 and troughed at $1.0 billion in Q4 2022.
  • A 5-year average of $1.2 billion and a median of $1.1 billion in 2024 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities retreated 20.01% in 2022, then jumped 30.36% in 2025.
  • Over 5 years, Total Non-Current Liabilities stood at $1.0 billion in 2022, then rose by 6.9% to $1.1 billion in 2023, then increased by 6.59% to $1.1 billion in 2024, then increased by 19.48% to $1.4 billion in 2025, then decreased by 8.31% to $1.3 billion in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $1.3 billion, $1.4 billion, and $1.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 198.93 Bn 193.33 Bn 7.27 Bn -
2 Stryker 127.82 Bn 124.35 Bn 4.50 Bn 21.28 Bn
3 Medtronic 118.80 Bn 109.58 Bn 6.41 Bn 40.90 Bn
4 Boston Scientific 73.38 Bn 72.84 Bn 3.85 Bn 42.74 Bn
5 Edwards Lifesciences 51.95 Bn 47.70 Bn 1.35 Bn 2.57 Bn
6 Dexcom 34.44 Bn 32.50 Bn 830.00 Mn 3.68 Bn
7 GE HealthCare Technologies 33.91 Bn 31.80 Bn 2.18 Bn 23.89 Bn
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn 9.07 Bn
9 Steris 23.10 Bn 22.62 Bn 684.20 Mn 3.44 Bn
10 LivaNova 4.29 Bn 3.77 Bn 273.67 Mn 1.16 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.16 Bn
Mar 31, 2026 1.25 Bn
Dec 31, 2025 1.36 Bn
Sep 30, 2025 1.34 Bn
Jun 30, 2025 1.34 Bn
Mar 31, 2025 1.48 Bn
Dec 31, 2024 1.14 Bn
Sep 30, 2024 1.16 Bn
Jun 30, 2024 1.13 Bn
Mar 31, 2024 1.13 Bn
Dec 31, 2023 1.07 Bn
Sep 30, 2023 1.06 Bn
Jun 30, 2023 1.01 Bn
Mar 31, 2023 1.02 Bn
Dec 31, 2022 1.00 Bn
Sep 30, 2022 1.02 Bn
Jun 30, 2022 1.01 Bn
Mar 31, 2022 1.08 Bn
Dec 31, 2021 819.48 Mn
Sep 30, 2021 786.83 Mn